Table 1.
Variables | Experimental Group (n = 63) |
Control Group (n = 57) |
Comparator Group (n = 58) |
p |
---|---|---|---|---|
Age (year) | 41.0 ± 9.1 (24.0–60.0) | 42.7 ± 11.4 (21.0–75.0) | 42.4 ± 9.2 (24.0–70.0) | 0.607 1 |
Height (cm) | 159.8 ± 6.3 (130.0–172.0) | 160.0 ± 4.5 (152.0–170.0) | 159.7 ± 5.5 (148.0–170.0) | 0.965 2 |
Weight (kg) | 59.0 ± 9.9 (37.0–105.0) | 60.8 ± 12.7 (41.3–108.6) | 59.7 ± 9.6 (45.2–89.1) | 0.900 2 |
Body Mass Index (kg/m2) | 23.2 ± 3.9 (17.4–42.6) | 23.8 ± 4.9 (15.9–41.9) | 23.5 ± 3.8 (16.5–35.2) | 0.929 2 |
Co-morbidity | - | - | - | 0.722 3 |
Hypertension | 4 (6.3) | 6 (10.5) | 4 (6.9) | 0.660 3 |
Diabetes | 1 (16) | 1 (1.8) | 2 (3.4) | 0.752 3 |
Dyslipidemia | 0 | 2 (3.5) | 3 (5.2) | 0.211 3 |
Others | 9 (14.3) | 10 (17.5) | 6 (10.3) | 0.538 3 |
Gynecologic disease | - | - | - | - |
Uterine myoma | 28 (44.4) | 22 (38.6) | 34 (58.6) | 0.085 3 |
Adenomyosis | 2 (3.2) | 5 (8.8) | 2 (3.4) | 0.299 3 |
Ovarian neoplasm | 34 (54.0) | 35 (61.4) | 29 (50.0) | 0.459 3 |
Cervical dysplasia | 1 (1.6) | 0 | 0 | 0.399 3 |
Endometrial hyperplasia | 1 (1.6) | 1 (1.8) | 1 (1.7) | 0.997 3 |
Surgical approach | - | - | - | 0.012 3 |
Laparotomy | 16 (25.4) | 7 (12.3) | 21 (36.2) | - |
Laparoscopy | 47 (74.6) | 50 (87.7) | 37 (63.8) | - |
Surgical procedure | - | - | - | - |
Myomectomy | 14 (22.2) | 4 (7.0) | 16 (27.6) | 0.014 3 |
Hysterectomy | 18 (28.6) | 24 (42.1) | 20 (34.5) | 0.298 3 |
Ovarian cystectomy | 25 (39.7) | 21 (36.8) | 16 (27.6) | 0.351 3 |
Salpingo-oophorectomy | 10 (15.9) | 18 (31.6) | 14 (24.1) | 0.128 3 |
Salpingectomy | 1 (1.6) | 3 (5.3) | 1 (1.7) | 0.396 3 |
Anatomical site of surgery | - | - | - | 0.278 3 |
Uterus only | 27 (42.9) | 18 (31.6) | 28 (48.3) | - |
Uterus + unilateral adnexa | 2 (3.2) | 3 (5.3) | 3 (5.2) | - |
Uterus + bilateral adnexa | 3 (4.8) | 7 (12.3) | 5 (8.6) | - |
Unilateral adnexa | 21 (33.3) | 13 (22.8) | 10 (17.2) | - |
Bilateral adnexa | 10 (15.9) | 16 (28.1) | 12 (20.7) | - |
Preoperative adhesion | - | - | - | 0.895 3 |
Present | 23 (36.5) | 19 (33.3) | 19 (32.8) | - |
Absent | 40 (63.5) | 38 (66.7) | 39 (67.2) | - |
Operative time (min) | 85.9 ± 53.3 (25–345) | 77.1 ± 42.8 (10–200) | 96.2 ± 42.9 (20–205) | 0.029 2 |
Presented with mean ± SD (range) or n (%). 1 ANOVA or 2 Kruskal–Wallis test and 3 chi-squared test were used. Abbreviations: SD, standard deviation.